Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What Really Mattered With Inovio's Q3 Update


Inovio Pharmaceuticals (NASDAQ: INO) stock isn't anywhere near its lofty levels set this summer. However, investors probably won't complain about a year-to-date gain of close to 170%.  

The biotech had an opportunity for a catalyst when it announced third-quarter results after the market closed on Monday. Here are the highlights from Inovio's Q3 update.

Image Source: Getty Images.

Continue reading


Source Fool.com

Like: 0
INO
Share

Comments